# Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia

> **NCT06689514** · EARLY_PHASE1 · RECRUITING · sponsor: **Yifeng Jing** · enrollment: 30 (estimated)

## Conditions studied

- Prostatic Hypertrophy, Benign

## Interventions

- **DRUG:** alpha receptor antagonist
- **DRUG:** Low dose Tranilast
- **DRUG:** High dose Tranilast

## Key facts

- **NCT ID:** NCT06689514
- **Lead sponsor:** Yifeng Jing
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06689514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06689514, "Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06689514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*